Latest Research
- Congenital Unilateral Pulmonary …
- Lindsay Burn Syndrome
- Cleft Palate X-linked
- Thanos Stewart Zonana Syndrome
- Ciguatera Fish Poisoning
- Chromosome 11p- Partial Deletion
- Familial Hyperlipoproteinemia Type 1
- Cerebellar Degeneration- Subacute
- Autosomal Dominant Partial Epilepsy …
- Argininosuccinic Aciduria
- Aniridia Mental Retardation Syndrome
- Alagille Syndrome
Research
Adenosine deaminase deficiency
- Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease.
- ADAR1 is required for hematopoietic progenitor cell survival via RNA editing.
- Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.
- [Late onset of primary immune deficiencies]
- RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.
- Pediatric neurological syndromes and inborn errors of purine metabolism.
- Determination of adenosine deaminase activity in dried blood spots by a nonradiochemical assay using reversed-phase high-performance liquid chromatography.
- Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.
- Ten years of gene therapy for primary immune deficiencies.
- [Gene therapy for severe combined immunodeficiency]
- Primary immunodeficiencies (PIDs) presenting with cytopenias.
- Update on gene therapy for immunodeficiencies.
- Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
- Gene therapy for adenosine deaminase deficiency.
- Late-onset adenosine deaminase deficiency presenting with Heck's disease.
- 20 years of gene therapy for SCID.
- [New roles of glutamate receptors in glias and gliomas]
- A novel mutation in the ADA gene causing severe combined immunodeficiency in an Arab patient: a case report.
- New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy.
- Progress and prospects: gene therapy for inherited immunodeficiencies.